Table 2.
Socio‐demographic characteristics of the population enrolled in the STAR III study in India
| Community‐based model | PLHIV network‐led model | Private practitioners model | Total | |
|---|---|---|---|---|
| Total | 79,324 (100) | 1668 (100) | 6984 (100) | 87,976 (100) |
| Place of recruitment | ||||
| CBO/NGO/other community‐based testing sites | 47,161 (59) | 170 (10) | 436 (6) | 47,767 (54) |
| Home visit | 21,889 (28) | 992 (59) | 34 (0.5) | 22,915 (26) |
| Private clinic/pharmacy | 233 (0.3) | 482 (30) | 6510 (93) | 7225 (8) |
| Virtual outreach | 560 (0.7) | 0 (0) | 0 (0) | 560 (0.6) |
| Other | 9481 (12) | 24 (1) | 4 (0.1) | 9509 (11) |
| Median age (IQR) | 30 (25−35) | 32 (24−42) | 32 (28−38) | 30 (26−35) |
| Age | ||||
| 18−24 years | 16,151 (20) | 425 (25) | 761 (11) | 17,337 (20) |
| 25−34 years | 41,078 (52) | 493 (30) | 3607 (51) | 45,178 (51) |
| 35−44 years | 18,231 (23) | 393 (24) | 2196 (31) | 20,820 (24) |
| >44 years | 3864 (5) | 357 (21) | 420 (6) | 4641 (5) |
| Gender | ||||
| Male | 51,479 (65) | 815 (49) | 5633 (81) | 57,927 (66) |
| Female | 23,008 (29) | 850 (51) | 1349 (19) | 25,207 (29) |
| Transgender | 4765 (6) | 3 (0.2) | 2 (<0.1) | 4770 (5) |
| Other | 72 (0.1) | 0 | 0 | 72 (0.1) |
| Population group | ||||
| FSW | 19,513 (25) | 24 (1) | 295 (4) | 19,832 (22) |
| MSM | 15,180 (19) | 26 (2) | 36 (0.5) | 15,242 (17) |
| TG | 4765 (6) | 3 (0.2) | 2 (<0.1) | 4770 (5) |
| PWID | 5528 (7) | 3 (0.2) | 2 (<0.1) | 5533 (6) |
| Partner/client of key population | 10,934 (14) | 24 (1) | 41 (0.6) | 10,999 (12) |
| Partner of PLHIV | 1855 (2) | 537 (32) | 3 (<0.1) | 2395 (3) |
| Family member of PLHIV | 0 | 340 (20) | 0 | 340 (0.4) |
| Private practitioner/other referrals | 353 (0.4) | 91 (5) | 6111 (87) | 6555 (7) |
| Self‐identified high‐risk individuals | 21,199 (27) | 620 (37) | 494 (7) | 22,313 (25) |
| Education (n = 87,493) | ||||
| No formal education | 5382 (7) | 123 (7) | 136 (2) | 5641 (6) |
| Primary | 30,128 (38) | 447 (27) | 2469 (35) | 33,044 (38) |
| High school | 36,451 (46) | 987 (59) | 3605 (52) | 41,043 (47) |
| Higher education | 6888 (9) | 103 (6) | 774 (11) | 7765 (9) |
| HIV risk perception (n = 86,599) | ||||
| Low risk | 22,218 (28) | 833 (51) | 1687 (24) | 24,738 (29) |
| Medium risk | 33,634 (43) | 413 (25) | 2953 (43) | 37,000 (43) |
| High risk | 11,953 (15) | 294 (18) | 839 (12) | 13,086 (15) |
| Don't know | 10,271 (13) | 97 (6) | 1407 (20) | 11,775 (14) |
| Last HIV test (n = 87,974) | ||||
| Never tested | 35,740 (45) | 1144 (69) | 5236 (75) | 42,120 (48) |
| 0−12 months | 26,874 (34) | 176 (11) | 706 (10) | 27,756 (32) |
| More than 12 months | 11,681 (15) | 290 (17) | 493 (7) | 12,464 (14) |
| Time since last test not known | 5027 (6) | 58 (3) | 549 (8) | 5634 (6) |
| Kit preference | ||||
| Blood‐based | 39,967 (50) | 713 (43) | 4526 (65) | 45,206 (51) |
| Oral‐fluid based | 39,357 (50) | 955 (57) | 2458 (35) | 42,770 (49) |
Abbreviations: CBO, community‐based organization; FSW, female sex worker; IQR, inter quartile range; MSM, men who have sex with men; NGO, non‐governmental organisation; PWID, people who inject drugs; TG, transgender people.